Kevin Kuykendall, CEO of Vivione Biosciences, Discusses Startup Companies (Exec Q&A) by Mark Carter Posted 5/7/2012 12:00 am Updated 3 years ago Kevin Kuykendall is the new chief executive at Vivione Biosciences, a Little Rock startup formerly known as Litmus Rapid-B. Want the Full Article? Get Unlimited Archive Access for $19.95 per Year Readers must pay to access stories older than 20 days. Purchase Now Already have archive access? Login to view this article.